AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congen...

por Matsushita, Tadashi, Suzuki, Nobuaki, Nagao, Azusa, Nagae, Chiai, Yamaguchi-Suita, Haruko, Kyogoku, Yui, Ioka, Akiko, Nogami, Keiji
Publicado 2022

ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database

por Ogawa, Yoshiyuki, Amano, Kagehiro, Matsuo-Tezuka, Yukari, Okada, Norihiro, Murakami, Yoichi, Nakamura, Takao, Yamaguchi-Suita, Haruko, Nogami, Keiji
Publicado 2022

AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, pha...

por Shima, Midori, Takedani, Hideyuki, Kitsukawa, Kaoru, Taki, Masashi, Ishiguro, Akira, Nagao, Azusa, Yamaguchi-Suita, Haruko, Kyogoku, Yui, Yoshida, Seitaro, Nogami, Keiji
Publicado 2022